{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T11:42:22Z","timestamp":1791805342847,"version":"4.3.4"},"reference-count":235,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,12,16]],"date-time":"2020-12-16T00:00:00Z","timestamp":1608076800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Chimeric antigen receptor (CAR) T cells provide new therapeutic options for patients with relapsed\/refractory hematologic malignancies. However, neurotoxicity is a frequent, and potentially fatal, complication. The spectrum of manifestations ranges from delirium and language dysfunction to seizures, coma, and fatal cerebral edema. This novel syndrome has been designated immune effector cell\u2013associated neurotoxicity syndrome (ICANS). In this review, we draw an arc from our current understanding of how systemic and potentially local cytokine release act on the CNS, toward possible preventive and therapeutic approaches. We systematically review reported correlations of secreted inflammatory mediators in the serum\/plasma and cerebrospinal fluid with the risk of ICANS in patients receiving CAR T cell therapy. Possible pathophysiologic impacts on the CNS are covered in detail for the most promising candidate cytokines, including IL-1, IL-6, IL-15, and GM-CSF. To provide insight into possible final common pathways of CNS inflammation, we place ICANS into the context of other systemic inflammatory conditions that are associated with neurologic dysfunction, including sepsis-associated encephalopathy, cerebral malaria, thrombotic microangiopathy, CNS infections, and hepatic encephalopathy. We then review in detail what is known about systemic cytokine interaction with components of the neurovascular unit, including endothelial cells, pericytes, and astrocytes, and how microglia and neurons respond to systemic inflammatory challenges. Current therapeutic approaches, including corticosteroids and blockade of IL-1 and IL-6 signaling, are reviewed in the context of what is known about the role of cytokines in ICANS. Throughout, we point out gaps in knowledge and possible new approaches for the investigation of the mechanism, prevention, and treatment of ICANS.<\/jats:p>","DOI":"10.3389\/fimmu.2020.577027","type":"journal-article","created":{"date-parts":[[2021,1,7]],"date-time":"2021-01-07T06:17:38Z","timestamp":1610000258000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":259,"title":["Cytokines in CAR T Cell\u2013Associated Neurotoxicity"],"prefix":"10.3389","volume":"11","author":[{"given":"Juliane","family":"Gust","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael","family":"Ponce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W. Conrad","family":"Liles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gwenn A.","family":"Garden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cameron J.","family":"Turtle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,12,16]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1007\/s40263-018-0582-9","article-title":"Neurotoxicity Associated with CD19-Targeted CAR-T Cell Therapies","volume":"32","author":"Gust","year":"2018","journal-title":"CNS Drugs"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1126\/science.aar6711","article-title":"CAR T cell immunotherapy for human cancer","volume":"359","author":"June","year":"2018","journal-title":"Science"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2019-130983","article-title":"Tisagenlecleucel Chimeric Antigen Receptor (CAR) T-Cell Therapy for Adults with Diffuse Large B-Cell Lymphoma (DLBCL): Real World Experience from the Center for International Blood & Marrow Transplant Research (CIBMTR) Cellular Therapy (CT) Registry","volume":"134","author":"Jaglowski","year":"2019","journal-title":"Blood"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2019-124750","article-title":"Post-Marketing Use Outcomes of an Anti-CD19 Chimeric Antigen Receptor (CAR) T Cell Therapy, Axicabtagene Ciloleucel (Axi-Cel), for the Treatment of Large B Cell Lymphoma (LBCL) in the United States (US)","volume":"134","author":"Pasquini","year":"2019","journal-title":"Blood"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2018.12.758","article-title":"ASTCT Consensus Grading for Cytokine Release Syndrome and Neurologic Toxicity Associated with Immune Effector Cells","volume":"25","author":"Lee","year":"2019","journal-title":"Biol Blood Marrow Transplant J Am Soc Blood Marrow Transplant"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1002\/ana.25315","article-title":"Neurotoxicity after CTL019 in a pediatric and young adult cohort","volume":"84","author":"Gofshteyn","year":"2018","journal-title":"Ann Neurol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-17-0698","article-title":"Endothelial Activation and Blood-Brain Barrier Disruption in Neurotoxicity after Adoptive Immunotherapy with CD19 CAR-T Cells","volume":"7","author":"Gust","year":"2017","journal-title":"Cancer Discovery"},{"key":"B8","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1002\/ana.25502","article-title":"Glial injury in neurotoxicity after pediatric CD19-directed chimeric antigen receptor T cell therapy","volume":"86","author":"Gust","year":"2019","journal-title":"Ann Neurol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1709866","article-title":"Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia","volume":"378","author":"Maude","year":"2018","journal-title":"N Engl J Med"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1707447","article-title":"Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma","volume":"377","author":"Neelapu","year":"2017","journal-title":"N Engl J Med"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awz053","article-title":"Neurological toxicities associated with chimeric antigen receptor T-cell therapy","volume":"142","author":"Rubin","year":"2019","journal-title":"Brain J Neurol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-17-1319","article-title":"Clinical and Biological Correlates of Neurotoxicity Associated with CAR T-cell Therapy in Patients with B-cell Acute Lymphoblastic Leukemia","volume":"8","author":"Santomasso","year":"2018","journal-title":"Cancer Discovery"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-16-0040","article-title":"Identification of Predictive Biomarkers for Cytokine Release Syndrome after Chimeric Antigen Receptor T cell Therapy for Acute Lymphoblastic Leukemia","volume":"6","author":"Teachey","year":"2016","journal-title":"Cancer Discovery"},{"key":"B14","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/B978-0-323-66181-2.00007-X","article-title":"Chapter 7 - Neurotoxicities After CAR T-Cell Immunotherapy","volume-title":"Chimeric Antigen Receptor T-Cell Therapies for Cancer","author":"Gust","year":"2020"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2019000952","article-title":"Comparing CAR T-cell toxicity grading systems: application of the ASTCT grading system and implications for management","volume":"4","author":"Pennisi","year":"2020","journal-title":"Blood Adv"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1007\/s11940-019-0580-3","article-title":"Chimeric Antigen Receptor T Cell-Related Neurotoxicity: Mechanisms, Clinical Presentation, and Approach to Treatment","volume":"21","author":"Rice","year":"2019","journal-title":"Curr Treat Options Neurol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1097\/CNQ.0000000000000302","article-title":"CAR T-Cell-Associated Neurotoxicity: Current Management and Emerging Treatment Strategies","volume":"43","author":"Rivera","year":"2020","journal-title":"Crit Care Nurs Q"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1136\/practneurol-2020-002550","article-title":"Neurotoxicity-CAR T-cell therapy: what the neurologist needs to know","volume":"20","author":"Neill","year":"2020","journal-title":"Pract Neurol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2019-129279","article-title":"Tisagenlecleucel Chimeric Antigen Receptor (CAR) T-Cell Therapy for Relapsed\/Refractory Children and Young Adults with Acute Lymphoblastic Leukemia (ALL): Real World Experience from the Center for International Blood and Marrow Transplant Research (CIBMTR) and Cellular Therapy (CT) Registry","volume":"134","author":"Grupp","year":"2019","journal-title":"Blood"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1709919","article-title":"Long-Term Follow-up of CD19 CAR Therapy in Acute Lymphoblastic Leukemia","volume":"378","author":"Park","year":"2018","journal-title":"N Engl J Med"},{"key":"B21","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1038\/nm.4441","article-title":"CD22-targeted CAR T cells induce remission in B-ALL that is naive or resistant to CD19-targeted CAR immunotherapy","volume":"24","author":"Fry","year":"2018","journal-title":"Nat Med"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-02-769208","article-title":"Intent-to-treat leukemia remission by CD19 CAR T cells of defined formulation and dose in children and young adults","volume":"129","author":"Gardner","year":"2017","journal-title":"Blood"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1172\/JCI85309","article-title":"CD19 CAR\u2013T cells of defined CD4+:CD8+ composition in adult B cell ALL patients","volume":"126","author":"Turtle","year":"2016","journal-title":"J Clin Invest"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(14)61403-3","article-title":"T cells expressing CD19 chimeric antigen receptors for acute lymphoblastic leukaemia in children and young adults: a phase 1 dose-escalation trial","volume":"385","author":"Lee","year":"2015","journal-title":"Lancet"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1407222","article-title":"Chimeric antigen receptor T cells for sustained remissions in leukemia","volume":"371","author":"Maude","year":"2014","journal-title":"N Engl J Med"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-019-0737-3","article-title":"Safety and feasibility of anti-CD19 CAR T cells with fully human binding domains in patients with B-cell lymphoma","volume":"26","author":"Brudno","year":"2020","journal-title":"Nat Med"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2016.71.3024","article-title":"Lymphoma Remissions Caused by Anti-CD19 Chimeric Antigen Receptor T Cells Are Associated With High Serum Interleukin-15 Levels","volume":"35","author":"Kochenderfer","year":"2017","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1708566","article-title":"Chimeric Antigen Receptor T Cells in Refractory B-Cell Lymphomas","volume":"377","author":"Schuster","year":"2017","journal-title":"N Engl J Med"},{"key":"B29","doi-asserted-by":"publisher","first-page":"355ra116","DOI":"10.1126\/scitranslmed.aaf8621","article-title":"Immunotherapy of non-Hodgkin\u2019s lymphoma with a defined ratio of CD8+ and CD4+ CD19-specific chimeric antigen receptor-modified T cells","volume":"8","author":"Turtle","year":"2016","journal-title":"Sci Transl Med"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-018-0010-1","article-title":"Determinants of response and resistance to CD19 chimeric antigen receptor (CAR) T cell therapy of chronic lymphocytic leukemia","volume":"24","author":"Fraietta","year":"2018","journal-title":"Nat Med"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2017.72.8519","article-title":"Durable Molecular Remissions in Chronic Lymphocytic Leukemia Treated With CD19-Specific Chimeric Antigen Receptor\u2013Modified T Cells After Failure of Ibrutinib","volume":"35","author":"Turtle","year":"2017","journal-title":"J Clin Oncol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1172\/JCI94306","article-title":"Clinical and immunological responses after CD30-specific chimeric antigen receptor-redirected lymphocytes","volume":"127","author":"Ramos","year":"2017","journal-title":"J Clin Invest"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-16-1365","article-title":"Autologous T Cells Expressing CD30 Chimeric Antigen Receptors for Relapsed or Refractory Hodgkin Lymphoma: An Open-Label Phase I Trial","volume":"23","author":"Wang","year":"2017","journal-title":"Clin Cancer Res Off J Am Assoc Cancer Res"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1817226","article-title":"Anti-BCMA CAR T-Cell Therapy bb2121 in Relapsed or Refractory Multiple Myeloma","volume":"380","author":"Raje","year":"2019","journal-title":"N Engl J Med"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1172\/JCI126397","article-title":"B cell maturation antigen-specific CAR T cells are clinically active in multiple myeloma","volume":"129","author":"Cohen","year":"2019","journal-title":"J Clin Invest"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2018.77.8084","article-title":"T Cells Genetically Modified to Express an Anti-B-Cell Maturation Antigen Chimeric Antigen Receptor Cause Remissions of Poor-Prognosis Relapsed Multiple Myeloma","volume":"36","author":"Brudno","year":"2018","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1186\/s13045-018-0681-6","article-title":"A phase 1, open-label study of LCAR-B38M, a chimeric antigen receptor T cell therapy directed against B cell maturation antigen, in patients with relapsed or refractory multiple myeloma","volume":"11","author":"Zhao","year":"2018","journal-title":"J Hematol OncolJ Hematol Oncol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-04-711903","article-title":"T cells expressing an anti-B-cell maturation antigen chimeric antigen receptor cause remissions of multiple myeloma","volume":"128","author":"Ali","year":"2016","journal-title":"Blood"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1038\/mt.2013.154","article-title":"Persistence and efficacy of second generation CAR T cell against the LeY antigen in acute myeloid leukemia","volume":"21","author":"Ritchie","year":"2013","journal-title":"Mol Ther J Am Soc Gene Ther"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1610497","article-title":"Regression of Glioblastoma after Chimeric Antigen Receptor T-Cell Therapy","volume":"375","author":"Brown","year":"2016","journal-title":"N Engl J Med"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aaa0984","article-title":"A single dose of peripherally infused EGFRvIII-directed CAR T cells mediates antigen loss and induces adaptive resistance in patients with recurrent glioblastoma","volume":"9","author":"O\u2019Rourke","year":"2017","journal-title":"Sci Transl Med"},{"key":"B42","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1007\/s40264-018-0760-1","article-title":"Benefit\u2013Risk Assessment of Blinatumomab in the Treatment of Relapsed\/Refractory B-Cell Precursor Acute Lymphoblastic Leukemia","volume":"42","author":"Stein","year":"2019","journal-title":"Drug Saf"},{"key":"B43","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/S1470-2045(14)71170-2","article-title":"Safety and activity of blinatumomab for adult patients with relapsed or refractory B-precursor acute lymphoblastic leukaemia: a multicentre, single-arm, phase 2 study","volume":"16","author":"Topp","year":"2015","journal-title":"Lancet Oncol"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-018-3497-0","article-title":"Neurologic adverse events in patients with relapsed\/refractory acute lymphoblastic leukemia treated with blinatumomab: management and mitigating factors","volume":"98","author":"Stein","year":"2019","journal-title":"Ann Hematol"},{"key":"B45","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s40164-017-0074-5","article-title":"Changes in clinical laboratory parameters and pharmacodynamic markers in response to blinatumomab treatment of patients with relapsed\/refractory ALL","volume":"6","author":"N\u00e4gele","year":"2017","journal-title":"Exp Hematol Oncol"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2010.32.7270","article-title":"Targeted Therapy With the T-Cell\u2013Engaging Antibody Blinatumomab of Chemotherapy-Refractory Minimal Residual Disease in B-Lineage Acute Lymphoblastic Leukemia Patients Results in High Response Rate and Prolonged Leukemia-Free Survival","volume":"29","author":"Topp","year":"2011","journal-title":"J Clin Oncol"},{"key":"B47","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1158\/0008-5472.CAN-19-1131","article-title":"Adhesion of T Cells to Endothelial Cells Facilitates Blinatumomab-Associated Neurologic Adverse Events","volume":"80","author":"Klinger","year":"2020","journal-title":"Cancer Res"},{"key":"B48","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/nrclinonc.2017.148","article-title":"Chimeric antigen receptor T-cell therapy - assessment and management of toxicities","volume":"15","author":"Neelapu","year":"2018","journal-title":"Nat Rev Clin Oncol"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1097\/WNP.0000000000000669","article-title":"EEG Correlates of Delirium in Children and Young Adults With CD19-Directed CAR T Cell Treatment-Related Neurotoxicity","author":"Gust","year":"2019","journal-title":"J Clin Neurophysiol"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000005910","article-title":"EEG findings in CAR T-cell therapy-related encephalopathy","volume":"91","author":"Herlopian","year":"2018","journal-title":"Neurology"},{"key":"B51","unstructured":"CeppiF Minimal Change in CAR T Cell Manufacturing Can Impact in Expansion and Side Effect of the CAR T Cell Therapy. in (ASH)"},{"key":"B52","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1186\/s40425-017-0289-3","article-title":"Clinical outcomes for the phase 2, single-arm, multicenter trial of JCAR015 in adult B-ALL (ROCKET Study)","volume":"5","author":"DeAngelo","year":"2017","journal-title":"J Immunother Cancer"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1002\/hon.2437_7","article-title":"Preliminary Results of Prophylactic Tocilizumab after Axicabtageneciloleucel (axi-cel; KTE-C19) Treatment for Patients with Refractory,Aggressive Non-Hodgkin Lymphoma (NHL)","volume":"130","author":"Locke","year":"2017","journal-title":"Blood"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1093\/jnen\/nly064","article-title":"Neuropathology of a Case With Fatal CAR T-Cell-Associated Cerebral Edema","volume":"77","author":"Torre","year":"2018","journal-title":"J Neuropathol Exp Neurol"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1007\/s00401-018-1809-z","article-title":"The meninges as barriers and facilitators for the movement of fluid, cells and pathogens related to the rodent and human CNS","volume":"135","author":"Weller","year":"2018","journal-title":"Acta Neuropathol (Berl)"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000002825","article-title":"Acute disseminated encephalomyelitis: Updates on an inflammatory CNS syndrome","volume":"87","author":"Pohl","year":"2016","journal-title":"Neurology"},{"key":"B57","article-title":"Acute Necrotizing Encephalopathy of Childhood: Correlation of MR Findings and Clinical Outcome","volume":"27","author":"Wong","year":"2006","journal-title":"Am J Neuroradiol"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1212\/CON.0000000000000240","article-title":"Arbovirus Infections","volume":"21","author":"Beckham","year":"2015","journal-title":"Contin Minneap Minn"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.3174\/ajnr.A3336","article-title":"Central Nervous System Involvement in Adults with Epidemic Hemolytic Uremic Syndrome","volume":"34","author":"Wengenroth","year":"2013","journal-title":"Am J Neuroradiol"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1097\/CJI.0000000000000241","article-title":"Systematic Evaluation of Neurotoxicity in Children and Young Adults Undergoing CD22 Chimeric Antigen Receptor T-Cell Therapy","volume":"41","author":"Shalabi","year":"2018","journal-title":"J Immunother Hagerstown Md 1997"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.00004.2013","article-title":"Cerebrospinal Fluid Secretion by the Choroid Plexus","volume":"93","author":"Damkier","year":"2013","journal-title":"Physiol Rev"},{"key":"B62","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.bbi.2014.08.007","article-title":"The blood-brain barrier in neuroimmunology: Tales of separation and assimilation","volume":"44","author":"Banks","year":"2015","journal-title":"Brain Behav Immun"},{"key":"B63","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.bbi.2016.03.010","article-title":"The blood-brain barrier in systemic inflammation","volume":"60","author":"Varatharaj","year":"2017","journal-title":"Brain Behav Immun"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-06-793141","article-title":"Kinetics and biomarkers of severe cytokine release syndrome after CD19 chimeric antigen receptor-modified T-cell therapy","volume":"130","author":"Hay","year":"2017","journal-title":"Blood"},{"key":"B65","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-019-13880-1","article-title":"Clonal kinetics and single-cell transcriptional profiling of CAR-T cells in patients undergoing CD19 CAR-T immunotherapy","volume":"11","author":"Sheih","year":"2020","journal-title":"Nat Commun"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2017.35.15_suppl.3019","article-title":"Biomarkers associated with neurotoxicity in adult patients with relapsed or refractory B-ALL (R\/R B-ALL) treated with CD19 CAR T cells","volume":"35","author":"Santomasso","year":"2017","journal-title":"J Clin Oncol"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1610544113","article-title":"Tethered IL-15 augments antitumor activity and promotes a stem-cell memory subset in tumor-specific T cells","volume":"113","author":"Hurton","year":"2016","journal-title":"Proc Natl Acad Sci USA"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-01-828343","article-title":"Preinfusion polyfunctional anti-CD19 chimeric antigen receptor T cells are associated with clinical outcomes in NHL","volume":"132","author":"Rossi","year":"2018","journal-title":"Blood"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V130.Suppl_1.2649.2649","article-title":"Neurological Consequences of Cytokine Release Syndrome Following Subcutaneous Recombinant IL-15 and Haploidentical Donor Natural Killer Cell Therapy for Advanced Acute Myeloid Leukemia","volume":"130","author":"Cooley","year":"2017","journal-title":"Blood"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-017-2100-1","article-title":"Haploidentical Natural Killer Cells Induce Remissions in Non-Hodgkin Lymphoma Patients With Low Levels of Immune-suppressor Cells","volume":"67","author":"Bachanova","year":"2018","journal-title":"Cancer Immunol Immunother CII"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1038\/nri3919","article-title":"IL-15 functions as a danger signal to regulate tissue-resident T cells and tissue destruction","volume":"15","author":"Jabri","year":"2015","journal-title":"Nat Rev Immunol"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1002\/glia.20920","article-title":"Blockade of IL-15 activity inhibits microglial activation through the NFkappaB, p38, and ERK1\/2 pathways, reducing cytokine and chemokine release","volume":"58","author":"Gomez-Nicola","year":"2010","journal-title":"Glia"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.119.028638","article-title":"IL (Interleukin)-15 Bridges Astrocyte-Microglia Crosstalk and Exacerbates Brain Injury Following Intracerebral Hemorrhage","volume":"51","author":"Shi Samuel","year":"2020","journal-title":"Stroke"},{"key":"B74","article-title":"Interferon-\u03b3 and Systemic Autoimmunity","volume":"16","author":"Pollard","year":"2013","journal-title":"Discovery Med"},{"key":"B75","unstructured":"The Multifaceted Role of Interferon-\u03b3 in Central Nervous System Autoimmune Demyelination SanvitoL ConstantinescuCS GranB HartBA\u2018t 2010"},{"key":"B76","first-page":"41","article-title":"Regulation of Interferon-\u03b3 During Innate and Adaptive Immune Responses","author":"Schoenborn","year":"2007"},{"key":"B77","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/s0165-5728(96)00155-5","article-title":"Analysis of B7-1 and B7-2 costimulatory ligands in cultured mouse microglia: upregulation by interferon-gamma and lipopolysaccharide and downregulation by interleukin-10, prostaglandin E2 and cyclic AMP-elevating agents","volume":"72","author":"Men\u00e8ndez Iglesias","year":"1997","journal-title":"J Neuroimmunol"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.178.2.1122","article-title":"Identification of Genes Selectively Regulated by IFNs in Endothelial Cells","volume":"178","author":"Indraccolo","year":"2007","journal-title":"J Immunol"},{"key":"B79","doi-asserted-by":"crossref","DOI":"10.4049\/jimmunol.161.5.2457","article-title":"IFN-\u03b3 Inhibits Activation-Induced Expression of E- and P-Selectin on Endothelial Cells","volume":"161","author":"Melrose","year":"1998","journal-title":"J Immunol"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1177\/0271678X17740793","article-title":"Neurovascular unit crosstalk: Pericytes and astrocytes modify cytokine secretion patterns of brain endothelial cells","volume":"38","author":"Banks","year":"2018","journal-title":"J Cereb Blood Flow Metab"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awt259","article-title":"IFN-\u03b3-dependent activation of the brain\u2019s choroid plexus for CNS immune surveillance and repair","volume":"136","author":"Kunis","year":"2013","journal-title":"Brain"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2015.00539","article-title":"Opposing Roles of Interferon-Gamma on Cells of the Central Nervous System in Autoimmune Neuroinflammation","volume":"6","author":"Ottum","year":"2015","journal-title":"Front Immunol"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajpath.2014.08.019","article-title":"Interferon-\u03b3 Safeguards Blood-Brain Barrier during Experimental Autoimmune Encephalomyelitis","volume":"184","author":"Ni","year":"2014","journal-title":"Am J Pathol"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.01675-19","article-title":"Gamma Interferon Alters Junctional Integrity via Rho Kinase, Resulting in Blood-Brain Barrier Leakage in Experimental Viral Encephalitis","volume":"10","author":"Bonney","year":"2019","journal-title":"mBio"},{"key":"B85","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1742-2094-5-7","article-title":"The role of interleukin-1 in neuroinflammation and Alzheimer disease: an evolving perspective","volume":"5","author":"Shaftel","year":"2008","journal-title":"J Neuroinflammation"},{"key":"B86","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1111\/imr.12621","article-title":"Overview of the IL-1 family in innate inflammation and acquired immunity","volume":"281","author":"Dinarello","year":"2018","journal-title":"Immunol Rev"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1097\/PCC.0000000000000078","article-title":"Therapeutic role of anakinra, an interleukin-1 receptor antagonist, in the management of secondary hemophagocytic lymphohistiocytosis\/sepsis\/multiple organ dysfunction\/macrophage activating syndrome in critically ill children*","volume":"15","author":"Rajasekaran","year":"2014","journal-title":"Pediatr Crit Care Med J Soc Crit Care Med World Fed Pediatr Intensive Crit Care Soc"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1016\/j.berh.2014.03.002","article-title":"MACROPHAGE ACTIVATION SYNDROME AND CYTOKINE DIRECTED THERAPIES","volume":"28","author":"Schulert","year":"2014","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa055137","article-title":"Neonatal-onset multisystem inflammatory disease responsive to interleukin-1beta inhibition","volume":"355","author":"Goldbach-Mansky","year":"2006","journal-title":"N Engl J Med"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-018-0036-4","article-title":"Monocyte-derived IL-1 and IL-6 are differentially required for cytokine-release syndrome and neurotoxicity due to CAR T cells","volume":"24","author":"Norelli","year":"2018","journal-title":"Nat Med"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20151437","article-title":"Myeloid cell transmigration across the CNS vasculature triggers IL-1\u03b2\u2013driven neuroinflammation during autoimmune encephalomyelitis in mice","volume":"213","author":"L\u00e9vesque","year":"2016","journal-title":"J Exp Med"},{"key":"B92","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.immuni.2018.12.012","article-title":"Cell-Type-Specific Interleukin 1 Receptor 1 Signaling in the Brain Regulates Distinct Neuroimmune Activities","volume":"50","author":"Liu","year":"2019","journal-title":"Immunity"},{"key":"B93","doi-asserted-by":"publisher","first-page":"e568543","DOI":"10.1155\/2015\/568543","article-title":"Pivotal Roles of GM-CSF in Autoimmunity and Inflammation","volume":"2015","author":"Shiomi","year":"2015","journal-title":"Mediators Inflammation"},{"key":"B94","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1182\/blood-2018-10-881722","article-title":"GM-CSF inhibition reduces cytokine release syndrome and neuroinflammation but enhances CAR-T cell function in xenografts","volume":"133","author":"Sterner","year":"2019","journal-title":"Blood"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2018-0028","article-title":"FDA Approval Summary: Tocilizumab for Treatment of Chimeric Antigen Receptor T Cell-Induced Severe or Life-Threatening Cytokine Release Syndrome","volume":"23","author":"Le","year":"2018","journal-title":"Oncologist"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2019001463","article-title":"Preemptive mitigation of CD19 CAR T-cell cytokine release syndrome without attenuation of antileukemic efficacy","volume":"134","author":"Gardner","year":"2019","journal-title":"Blood"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.7150\/ijbs.4679","article-title":"Interleukin-6, a Major Cytokine in the Central Nervous System","volume":"8","author":"Erta","year":"2012","journal-title":"Int J Biol Sci"},{"key":"B98","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1002\/1097-4547(20000701)61:1<10::AID-JNR2>3.0.CO;2-E","article-title":"Comparative evaluation of cytokine profiles and reactive gliosis supports a critical role for interleukin-6 in neuron-glia signaling during regeneration","volume":"61","author":"Streit","year":"2000","journal-title":"J Neurosci Res"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1002\/(sici)1098-1136(199703)19:3<227::aid-glia5>3.0.co;2-w","article-title":"Impaired neuroglial activation in interleukin-6 deficient mice","volume":"19","author":"Klein","year":"1997","journal-title":"Glia"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1038\/nrd.2016.278","article-title":"Therapeutic targeting of the angiopoietin-TIE pathway","volume":"16","author":"Saharinen","year":"2017","journal-title":"Nat Rev Drug Discovery"},{"key":"B101","doi-asserted-by":"publisher","first-page":"e957508","DOI":"10.4161\/21688362.2014.957508","article-title":"The angiopoietin-Tie2 signaling axis in the vascular leakage of systemic inflammation","volume":"3","author":"Milam","year":"2015","journal-title":"Tissue Barriers"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.00838","article-title":"Endothelial Activation: The Ang\/Tie Axis in Sepsis","volume":"9","author":"Leligdowicz","year":"2018","journal-title":"Front Immunol"},{"key":"B103","doi-asserted-by":"publisher","first-page":"358ra128","DOI":"10.1126\/scitranslmed.aaf6812","article-title":"Dysregulation of angiopoietin-1 plays a mechanistic role in the pathogenesis of cerebral malaria","volume":"8","author":"Higgins","year":"2016","journal-title":"Sci Transl Med"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1186\/1475-2875-12-50","article-title":"A clinicopathological correlation of the expression of the angiopoietin-Tie-2 receptor pathway in the brain of adults with Plasmodium falciparum malaria","volume":"12","author":"Prapansilp","year":"2013","journal-title":"Malar J"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.0914-18.2018","article-title":"Angiopoietin\/Tie2 Axis Regulates the Age-at-Injury Cerebrovascular Response to Traumatic Brain Injury","volume":"38","author":"Brickler","year":"2018","journal-title":"J Neurosci Off J Soc Neurosci"},{"key":"B106","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1146\/annurev.immunol.19.1.683","article-title":"Interleukin-10 and the Interleukin-10 Receptor","volume":"19","author":"Moore","year":"2001","journal-title":"Annu Rev Immunol"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.1136\/gut.50.2.191","article-title":"Treatment of Crohn\u2019s disease with recombinant human interleukin 10 induces the proinflammatory cytokine interferon \u03b3","volume":"50","author":"Tilg","year":"2002","journal-title":"Gut"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.1002\/bies.201300004","article-title":"Pegylated IL-10 induces cancer immunity","volume":"35","author":"Mumm","year":"2013","journal-title":"BioEssays"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-016-0763-8","article-title":"Balancing the immune response in the brain: IL-10 and its regulation","volume":"13","author":"Lobo-Silva","year":"2016","journal-title":"J Neuroinflammation"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.4161\/onci.19855","article-title":"OX40 costimulation by a chimeric antigen receptor abrogates CD28 and IL-2 induced IL-10 secretion by redirected CD4+ T cells","volume":"1","author":"Hombach","year":"2012","journal-title":"Oncoimmunology"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-99-119359","article-title":"Pegilodecakin, a Pegylated Human IL-10 (AM0010), Enhances the Cytotoxicity of CAR-T Cells in Vitro and In Vivo","volume":"132","author":"McCauley","year":"2018","journal-title":"Blood"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.1016\/j.gpb.2019.03.002","article-title":"Single-cell Analysis of CAR-T Cell Activation Reveals A Mixed TH1\/TH2 Response Independent of Differentiation","volume":"17","author":"Xhangolli","year":"2019","journal-title":"Genomics Proteomics Bioinf"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2019.1571893","article-title":"CRISPR\/Cas9-based genome editing in the era of CAR T cell immunotherapy","volume":"15","author":"Salas-Mckee","year":"2019","journal-title":"Hum Vaccines Immunother"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcyt.2017.04.001","article-title":"Monocyte lineage-derived IL-6 does not affect chimeric antigen receptor T-cell function","volume":"19","author":"Singh","year":"2017","journal-title":"Cytotherapy"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.AC119.007558","article-title":"Granulocyte-macrophage colony-stimulating factor inactivation in CAR T-Cells prevents monocyte-dependent release of key cytokine release syndrome mediators","volume":"294","author":"Sachdeva","year":"2019","journal-title":"J Biol Chem"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.1038\/nature06185","article-title":"Phagocyte-derived catecholamines enhance acute inflammatory injury","volume":"449","author":"Flierl","year":"2007","journal-title":"Nature"},{"key":"B117","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1038\/s41586-018-0774-y","article-title":"Disruption of a self-amplifying catecholamine loop reduces cytokine release syndrome","volume":"564","author":"Staedtke","year":"2018","journal-title":"Nature"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-08-802413","article-title":"Cytokine release syndrome associated with chimeric-antigen receptor T-cell therapy: clinicopathological insights","volume":"130","author":"Obstfeld","year":"2017","journal-title":"Blood"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.3390\/ijms16059949","article-title":"Pathogenesis of Brain Edema and Investigation into Anti-Edema Drugs","volume":"16","author":"Michinaga","year":"2015","journal-title":"Int J Mol Sci"},{"key":"B120","doi-asserted-by":"crossref","DOI":"10.1007\/3-211-30714-1_91","article-title":"Inflammation and brain edema: new insights into the role of chemokines and their receptors","volume-title":"Brain Edema XIII Acta Neurochirurgica Supplementum","author":"Stamatovic","year":"2006"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0b013e3181b6ed58","article-title":"Sepsis-associated encephalopathy and its differential diagnosis","volume":"37","author":"Iacobone","year":"2009","journal-title":"Crit Care Med"},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.1038\/nrneurol.2013.177","article-title":"Imaging in sepsis-associated encephalopathy\u2013insights and opportunities","volume":"9","author":"Stubbs","year":"2013","journal-title":"Nat Rev Neurol"},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2010.1553","article-title":"Long-term cognitive impairment and functional disability among survivors of severe sepsis","volume":"304","author":"Iwashyna","year":"2010","journal-title":"JAMA"},{"key":"B124","doi-asserted-by":"publisher","first-page":"R297","DOI":"10.1186\/cc10598","article-title":"Biomarkers associated with delirium in critically ill patients and their relation with long-term subjective cognitive dysfunction; indications for different pathways governing delirium in inflamed and noninflamed patients","volume":"15","author":"van den Boogaard","year":"2011","journal-title":"Crit Care Lond Engl"},{"key":"B125","doi-asserted-by":"publisher","first-page":"R140","DOI":"10.1186\/cc9205","article-title":"Cerebral microcirculation is impaired during sepsis: an experimental study","volume":"14","author":"Taccone","year":"2010","journal-title":"Crit Care"},{"key":"B126","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1111\/j.1600-0404.2007.00809.x","article-title":"Acute encephalopathy associated with influenza and other viral infections","volume":"115","author":"Mizuguchi","year":"2007","journal-title":"Acta Neurol Scand"},{"key":"B127","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1080\/0036554021000026986","article-title":"Cerebrospinal fluid and serum levels of cytokines and soluble tumor necrosis factor receptor in influenza virus-associated encephalopathy","volume":"35","author":"Ichiyama","year":"2003","journal-title":"Scand J Infect Dis"},{"key":"B128","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2004.03.012","article-title":"Analysis of cytokine levels and NF-kappaB activation in peripheral blood mononuclear cells in influenza virus-associated encephalopathy","volume":"27","author":"Ichiyama","year":"2004","journal-title":"Cytokine"},{"key":"B129","doi-asserted-by":"publisher","DOI":"10.1016\/j.braindev.2008.11.005","article-title":"Serum and cerebrospinal fluid levels of cytokines in acute encephalopathy associated with human herpesvirus-6 infection","volume":"31","author":"Ichiyama","year":"2009","journal-title":"Brain Dev"},{"key":"B130","doi-asserted-by":"publisher","DOI":"10.1016\/S0887-8994(01)00394-0","article-title":"Acute lethal encephalopathy in systemic juvenile rheumatoid arthritis","volume":"26","author":"Ueno","year":"2002","journal-title":"Pediatr Neurol"},{"key":"B131","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.02016","article-title":"Cerebral Malaria in Mouse and Man","volume":"9","author":"Ghazanfari","year":"2018","journal-title":"Front Immunol"},{"key":"B132","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1400116","article-title":"Brain swelling and death in children with cerebral malaria","volume":"372","author":"Seydel","year":"2015","journal-title":"N Engl J Med"},{"key":"B133","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2017.00324","article-title":"Cytokines and Chemokines in Cerebral Malaria Pathogenesis","volume":"7","author":"Dunst","year":"2017","journal-title":"Front Cell Infect Microbiol"},{"key":"B134","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.72.10.5630-5637.2004","article-title":"Serum Levels of the Proinflammatory Cytokines Interleukin-1 Beta (IL-1\u03b2), IL-6, IL-8, IL-10, Tumor Necrosis Factor Alpha, and IL-12(p70) in Malian Children with Severe Plasmodium falciparum Malaria and Matched Uncomplicated Malaria or Healthy Controls","volume":"72","author":"Lyke","year":"2004","journal-title":"Infect Immun"},{"key":"B135","doi-asserted-by":"publisher","DOI":"10.1128\/CVI.00533-16","article-title":"Cytokine Profiles in Malawian Children Presenting with Uncomplicated Malaria, Severe Malarial Anemia, and Cerebral Malaria","volume":"24","author":"Mandala","year":"2017","journal-title":"Clin Vaccine Immunol CVI"},{"key":"B136","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1086\/504720","article-title":"Clusters of Cytokines Determine Malaria Severity in Plasmodium falciparum\u2013Infected Patients from Endemic Areas of Central India","volume":"194","author":"Prakash","year":"2006","journal-title":"J Infect Dis"},{"key":"B137","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiq041","article-title":"Distinct clinical and immunologic profiles in severe malarial anemia and cerebral malaria in Zambia","volume":"203","author":"Thuma","year":"2011","journal-title":"J Infect Dis"},{"key":"B138","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1186\/s12936-018-2590-0","article-title":"Brain swelling is independent of peripheral plasma cytokine levels in Malawian children with cerebral malaria","volume":"17","author":"Harawa","year":"2018","journal-title":"Malar J"},{"key":"B139","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.pathmechdis.3.121806.154311","article-title":"Pathogenesis of Thrombotic Microangiopathies","volume":"3","author":"Zheng","year":"2008","journal-title":"Annu Rev Pathol"},{"key":"B140","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2007010062","article-title":"Is There a Shared Pathophysiology for Thrombotic Thrombocytopenic Purpura and Hemolytic-Uremic Syndrome","volume":"18","author":"Desch","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"B141","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-02-078170","article-title":"Von Willebrand factor, ADAMTS13, and thrombotic thrombocytopenic purpura","volume":"112","author":"Sadler","year":"2008","journal-title":"Blood"},{"key":"B142","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2012-07-442285","article-title":"Unwinding the von Willebrand factor strings puzzle","volume":"121","author":"De Ceunynck","year":"2013","journal-title":"Blood"},{"key":"B143","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2004-01-0107","article-title":"Effects of inflammatory cytokines on the release and cleavage of the endothelial cell-derived ultralarge von Willebrand factor multimers under flow","volume":"104","author":"Bernardo","year":"2004","journal-title":"Blood"},{"key":"B144","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2008.02989.x","article-title":"Inflammatory Cytokines Inhibit ADAMTS13 Synthesis in Hepatic Stellate Cells and Endothelial Cells","volume":"6","author":"Cao","year":"2008","journal-title":"J Thromb Haemost JTH"},{"key":"B145","doi-asserted-by":"publisher","DOI":"10.1517\/17425255.3.2.209","article-title":"Toxicity as a result of immunostimulation by biologics","volume":"3","author":"Gribble","year":"2007","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"B146","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/civ473","article-title":"Neurological Complications of PCR-Proven M. pneumoniae Infections in Children: Prodromal Illness Duration May Reflect Pathogenetic Mechanism","volume":"61","author":"Al-Zaidy","year":"2015","journal-title":"Clin Infect Dis"},{"key":"B147","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e3182a9f531","article-title":"Herpes simplex virus\u20131 encephalitis can trigger anti-NMDA receptor encephalitis: Case report","volume":"81","author":"Leypoldt","year":"2013","journal-title":"Neurology"},{"key":"B148","doi-asserted-by":"publisher","DOI":"10.1086\/344939","article-title":"Pathophysiology of Bacterial Meningitis: Mechanism(s) of Neuronal Injury","volume":"186","author":"Scheld","year":"2002","journal-title":"J Infect Dis"},{"key":"B149","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2009.09.013","article-title":"The clinical spectrum and immunobiology of parainfectious neuromyelitis optica (Devic) syndromes","volume":"34","author":"Sellner","year":"2010","journal-title":"J Autoimmun"},{"key":"B150","doi-asserted-by":"publisher","first-page":"e0205501","DOI":"10.1371\/journal.pone.0205501","article-title":"Potential role of CSF cytokine profiles in discriminating infectious from non-infectious CNS disorders","volume":"13","author":"Fortuna","year":"2018","journal-title":"PloS One"},{"key":"B151","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.64.12.4883-4890.1996","article-title":"Roles of proinflammatory and anti-inflammatory cytokines in pathophysiology of bacterial meningitis and effect of adjunctive therapy","volume":"64","author":"van Furth","year":"1996","journal-title":"Infect Immun"},{"key":"B152","doi-asserted-by":"publisher","DOI":"10.1086\/423328","article-title":"Proinflammatory Cytokines and Chemokines in Humans with Japanese Encephalitis","volume":"190","author":"Winter","year":"2004","journal-title":"J Infect Dis"},{"key":"B153","doi-asserted-by":"publisher","DOI":"10.1016\/j.pedneo.2015.11.002","article-title":"Analysis of Fulminant Cerebral Edema in Acute Pediatric Encephalitis","volume":"57","author":"Lan","year":"2016","journal-title":"Pediatr Neonatol"},{"key":"B154","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v19.i48.9240","article-title":"Pathophysiology of cerebral oedema in acute liver failure","volume":"19","author":"Scott","year":"2013","journal-title":"World J Gastroenterol WJG"},{"key":"B155","doi-asserted-by":"publisher","first-page":"S96","DOI":"10.1016\/j.jceh.2014.02.004","article-title":"Pathogenesis of Hepatic Encephalopathy and Brain Edema in Acute Liver Failure","volume":"5","author":"Butterworth","year":"2015","journal-title":"J Clin Exp Hepatol"},{"key":"B156","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-4159.2009.05981.x","article-title":"Cerebral inflammation contributes to encephalopathy and brain edema in acute liver failure: protective effect of minocycline","volume":"109","author":"Jiang","year":"2009","journal-title":"J Neurochem"},{"key":"B157","doi-asserted-by":"publisher","DOI":"10.3171\/jns.2000.92.1.0108","article-title":"Intracerebral administration of interleukin-1\u03b2 and induction of inflammation, apoptosis, and vasogenic edema","volume":"92","author":"Holmin","year":"2000","journal-title":"J Neurosurg"},{"key":"B158","doi-asserted-by":"publisher","DOI":"10.1038\/sj.jcbfm.9600086","article-title":"Tumor necrosis factor-alpha neutralization reduced cerebral edema through inhibition of matrix metalloproteinase production after transient focal cerebral ischemia","volume":"25","author":"Hosomi","year":"2005","journal-title":"J Cereb Blood Flow Metab Off J Int Soc Cereb Blood Flow Metab"},{"key":"B159","doi-asserted-by":"publisher","DOI":"10.1038\/ni.3666","article-title":"The movers and shapers in immune privilege of the CNS","volume":"18","author":"Engelhardt","year":"2017","journal-title":"Nat Immunol"},{"key":"B160","doi-asserted-by":"publisher","first-page":"147ra111","DOI":"10.1126\/scitranslmed.3003748","article-title":"A Paravascular Pathway Facilitates CSF Flow Through the Brain Parenchyma and the Clearance of Interstitial Solutes, Including Amyloid \u03b2","volume":"4","author":"Iliff","year":"2012","journal-title":"Sci Transl Med"},{"key":"B161","doi-asserted-by":"publisher","DOI":"10.1517\/17425247.2016.1171315","article-title":"CSF, blood-brain barrier, and brain drug delivery","volume":"13","author":"Pardridge","year":"2016","journal-title":"Expert Opin Drug Delivery"},{"key":"B162","doi-asserted-by":"publisher","DOI":"10.1177\/1073858418760481","article-title":"Neural Mechanisms of Inflammation-Induced Fever","volume":"24","author":"Blomqvist","year":"2018","journal-title":"Neurosci Rev J Bringing Neurobiol Neurol Psychiatry"},{"key":"B163","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.neuron.2018.02.022","article-title":"Regulation of body temperature by the nervous system","volume":"98","author":"Tan","year":"2018","journal-title":"Neuron"},{"key":"B164","doi-asserted-by":"publisher","DOI":"10.1038\/nrd.2015.21","article-title":"From blood\u2013brain barrier to blood\u2013brain interface: new opportunities for CNS drug delivery","volume":"15","author":"Banks","year":"2016","journal-title":"Nat Rev Drug Discovery"},{"key":"B165","doi-asserted-by":"publisher","DOI":"10.1093\/femspd\/ftx038","article-title":"Comparison of the inflammatory response of brain microvascular and peripheral endothelial cells following infection with Neisseria meningitidis","volume":"75","author":"Dick","year":"2017","journal-title":"Pathog Dis"},{"key":"B166","doi-asserted-by":"publisher","DOI":"10.1007\/s10571-008-9322-x","article-title":"Detachment of Brain Pericytes from the Basal Lamina is Involved in Disruption of the Blood\u2013Brain Barrier Caused by Lipopolysaccharide-Induced Sepsis in Mice","volume":"29","author":"Nishioku","year":"2009","journal-title":"Cell Mol Neurobiol"},{"key":"B167","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-8993(99)02189-7","article-title":"Brain endothelial cell production of a neuroprotective cytokine, interleukin-6, in response to noxious stimuli","volume":"851","author":"Reyes","year":"1999","journal-title":"Brain Res"},{"key":"B168","doi-asserted-by":"publisher","DOI":"10.1038\/nri3843","article-title":"Fever and the thermal regulation of immunity: the immune system feels the heat","volume":"15","author":"Evans","year":"2015","journal-title":"Nat Rev Immunol"},{"key":"B169","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12974-015-0346-0","article-title":"Pro-inflammatory TNF\u03b1 and IL-1\u03b2 differentially regulate the inflammatory phenotype of brain microvascular endothelial cells","volume":"12","author":"O\u2019Carroll","year":"2015","journal-title":"J Neuroinflammation"},{"key":"B170","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2020.00042","article-title":"Single Cell Analysis in Vascular Biology","volume":"7","author":"Chavkin","year":"2020","journal-title":"Front Cardiovasc Med"},{"key":"B171","doi-asserted-by":"publisher","DOI":"10.1038\/srep35108","article-title":"Analysis of the brain mural cell transcriptome","volume":"6","author":"He","year":"2016","journal-title":"Sci Rep"},{"key":"B172","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.51413","article-title":"Endothelial heterogeneity across distinct vascular beds during homeostasis and inflammation","volume":"9","author":"Jambusaria","year":"2020","journal-title":"eLife"},{"key":"B173","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1016\/j.cell.2020.01.015","article-title":"Single-Cell Transcriptome Atlas of Murine Endothelial Cells","volume":"180","author":"Kalucka","year":"2020","journal-title":"Cell"},{"key":"B174","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.tips.2016.12.001","article-title":"Brain Pericytes As Mediators of Neuroinflammation","volume":"38","author":"Rustenhoven","year":"2017","journal-title":"Trends Pharmacol Sci"},{"key":"B175","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1186\/s12974-018-1167-8","article-title":"Unique and shared inflammatory profiles of human brain endothelia and pericytes","volume":"15","author":"Smyth","year":"2018","journal-title":"J Neuroinflammation"},{"key":"B176","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.celrep.2017.12.016","article-title":"Dynamic Remodeling of Pericytes In\u00a0Vivo Maintains Capillary Coverage in the Adult Mouse Brain","volume":"22","author":"Berthiaume","year":"2018","journal-title":"Cell Rep"},{"key":"B177","doi-asserted-by":"publisher","DOI":"10.3233\/CH-189132","article-title":"The controversial origin of pericytes during angiogenesis \u2013 Implications for cell-based therapeutic angiogenesis and cell-based therapies","volume":"69","author":"Blocki","year":"2018","journal-title":"Clin Hemorheol Microcirc"},{"key":"B178","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/4123605","article-title":"Role and Molecular Mechanisms of Pericytes in Regulation of Leukocyte Diapedesis in Inflamed Tissues","volume":"2019","author":"Rudziak","year":"2019","journal-title":"Mediators Inflammation"},{"key":"B179","doi-asserted-by":"publisher","first-page":"644120","DOI":"10.1101\/644120","article-title":"Pericytes regulate vascular immune homeostasis in the CNS","author":"T\u00f6r\u00f6k","year":"2019","journal-title":"bioRxiv"},{"key":"B180","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2018.00488","article-title":"Microglia in Neurological Diseases: A Road Map to Brain-Disease Dependent-Inflammatory Response","volume":"12","author":"Bachiller","year":"2018","journal-title":"Front Cell Neurosci"},{"key":"B181","doi-asserted-by":"publisher","DOI":"10.1007\/s11481-006-9015-5","article-title":"Microglia Biology in Health and Disease","volume":"1","author":"Garden","year":"2006","journal-title":"J Neuroimmune Pharmacol"},{"key":"B182","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1742-2094-8-121","article-title":"Pro-inflammatory cytokines and lipopolysaccharide induce changes in cell morphology, and upregulation of ERK1\/2, iNOS and sPLA 2 -IIA expression in astrocytes and microglia","volume":"8","author":"Sheng","year":"2011","journal-title":"J Neuroinflammation"},{"key":"B183","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2018.00215","article-title":"Microglia Responses to Pro-inflammatory Stimuli (LPS, IFN\u03b3+TNF\u03b1) and Reprogramming by Resolving Cytokines (IL-4, IL-10)","volume":"12","author":"Lively","year":"2018","journal-title":"Front Cell Neurosci"},{"key":"B184","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1900317","article-title":"Long-Term Microgliosis Driven by Acute Systemic Inflammation","volume":"203","author":"Trzeciak","year":"2019","journal-title":"J Immunol Baltim Md 1950"},{"key":"B185","doi-asserted-by":"publisher","DOI":"10.1038\/s41593-018-0242-x","article-title":"Microglia in neurodegeneration","volume":"21","author":"Hickman","year":"2018","journal-title":"Nat Neurosci"},{"key":"B186","doi-asserted-by":"publisher","DOI":"10.1016\/j.febslet.2011.08.033","article-title":"Role of microglia in CNS inflammation","volume":"585","author":"Graeber","year":"2011","journal-title":"FEBS Lett"},{"key":"B187","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-019-0262-0","article-title":"Neuroinflammation and neurodegeneration in human brain at single-cell resolution","volume":"20","author":"Colonna","year":"2020","journal-title":"Nat Rev Immunol"},{"key":"B188","doi-asserted-by":"publisher","DOI":"10.1038\/s41593-019-0532-y","article-title":"Mapping microglia states in the human brain through the integration of high-dimensional techniques","volume":"22","author":"Sankowski","year":"2019","journal-title":"Nat Neurosci"},{"key":"B189","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1016\/j.cell.2019.11.010","article-title":"Cross-Species Single-Cell Analysis Reveals Divergence of the Primate Microglia Program","volume":"179","author":"Geirsdottir","year":"2019","journal-title":"Cell"},{"key":"B190","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.immuni.2018.11.004","article-title":"Single-Cell RNA Sequencing of Microglia throughout the Mouse Lifespan and in the Injured Brain Reveals Complex Cell-State Changes","volume":"50","author":"Hammond","year":"2019","journal-title":"Immunity"},{"key":"B191","doi-asserted-by":"publisher","first-page":"2020.03.10.985895","DOI":"10.1101\/2020.03.10.985895","article-title":"Single cell RNA-seq analysis reveals compartment-specific heterogeneity and plasticity of microglia","author":"Zheng","year":"2020","journal-title":"bioRxiv"},{"key":"B192","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1038\/s41586-019-1404-z","article-title":"Neuronal vulnerability and multilineage diversity in multiple sclerosis","volume":"573","author":"Schirmer","year":"2019","journal-title":"Nature"},{"key":"B193","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-018-0023-4","article-title":"Innate immune memory in the brain shapes neurological disease hallmarks","volume":"556","author":"Wendeln","year":"2018","journal-title":"Nature"},{"key":"B194","doi-asserted-by":"publisher","DOI":"10.1177\/0271678X15617172","article-title":"Molecular pathophysiology of cerebral edema","volume":"36","author":"Stokum","year":"2016","journal-title":"J Cereb Blood Flow Metab Off J Int Soc Cereb Blood Flow Metab"},{"key":"B195","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1015217108","article-title":"Critical role of aquaporin-4 (AQP4) in astrocytic Ca2+ signaling events elicited by cerebral edema","volume":"108","author":"Thrane","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B196","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1742-2094-7-66","article-title":"Marked potentiation of cell swelling by cytokines in ammonia-sensitized cultured astrocytes","volume":"7","author":"Rao","year":"2010","journal-title":"J Neuroinflammation"},{"key":"B197","doi-asserted-by":"publisher","DOI":"10.1172\/JCI60842","article-title":"Astrocyte-derived VEGF-A drives blood-brain barrier disruption in CNS inflammatory disease","volume":"122","author":"Argaw","year":"2012","journal-title":"J Clin Invest"},{"key":"B198","doi-asserted-by":"publisher","DOI":"10.1038\/nrn3898","article-title":"Astrocyte barriers to neurotoxic inflammation","volume":"16","author":"Sofroniew","year":"2015","journal-title":"Nat Rev Neurosci"},{"key":"B199","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1016\/j.cell.2018.06.021","article-title":"Molecular Architecture of the Mouse Nervous System","volume":"174","author":"Zeisel","year":"2018","journal-title":"Cell"},{"key":"B200","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2017.06.008","article-title":"Mechanisms and Therapeutic Relevance of Neuro-immune Communication","volume":"46","author":"Chavan","year":"2017","journal-title":"Immunity"},{"key":"B201","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1186\/s12974-017-0974-7","article-title":"Analysis of plasma multiplex cytokines and increased level of IL-10 and IL-1Ra cytokines in febrile seizures","volume":"14","author":"Kim","year":"2017","journal-title":"J Neuroinflammation"},{"key":"B202","doi-asserted-by":"publisher","DOI":"10.1016\/j.yfrne.2011.12.002","article-title":"Cytokines and brain excitability","volume":"33","author":"Galic","year":"2012","journal-title":"Front Neuroendocrinol"},{"key":"B203","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1242\/jeb.073411","article-title":"Immune\u2013neural connections: how the immune system\u2019s response to infectious agents influences behavior","volume":"216","author":"McCusker","year":"2013","journal-title":"J Exp Biol"},{"key":"B204","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpsychores.2006.11.013","article-title":"Cytokines and acute phase response in delirium","volume":"62","author":"de Rooij","year":"2007","journal-title":"J Psychosom Res"},{"key":"B205","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1038\/nrclinonc.2018.19","article-title":"Toxicity management after chimeric antigen receptor T cell therapy: one size does not fit \u201cALL","volume":"15","author":"Teachey","year":"2018","journal-title":"Nat Rev Clin Oncol"},{"key":"B206","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.cytogfr.2016.05.002","article-title":"Lu NZ. A gradient of glucocorticoid sensitivity among helper T cell cytokines","volume":"31","author":"Banuelos","year":"2016","journal-title":"Cytokine Growth Factor Rev"},{"key":"B207","doi-asserted-by":"publisher","DOI":"10.1159\/000014099","article-title":"Effects of Dexamethasone on IL-1\u03b2, IL-6, and TNF-\u03b1 Production by Mononuclear Cells of Newborns and Adults","volume":"75","author":"Bessler","year":"1999","journal-title":"Neonatology"},{"key":"B208","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.07-0273","article-title":"Dexamethasone Inhibits High Glucose\u2013, TNF-\u03b1\u2013, and IL-1\u03b2\u2013Induced Secretion of Inflammatory and Angiogenic Mediators from Retinal Microvascular Pericytes","volume":"49","author":"Nehm\u00e9","year":"2008","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"B209","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.89.21.9991","article-title":"A mechanism for the antiinflammatory effects of corticosteroids: the glucocorticoid receptor regulates leukocyte adhesion to endothelial cells and expression of endothelial-leukocyte adhesion molecule 1 and intercellular adhesion molecule 1","volume":"89","author":"Cronstein","year":"1992","journal-title":"Proc Natl Acad Sci"},{"key":"B210","doi-asserted-by":"publisher","DOI":"10.1172\/JCI118927","article-title":"Mechanism of dexamethasone suppression of brain tumor-associated vascular permeability in rats. Involvement of the glucocorticoid receptor and vascular permeability factor","volume":"98","author":"Heiss","year":"1996","journal-title":"J Clin Invest"},{"key":"B211","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-04-703751","article-title":"Toxicities of chimeric antigen receptor T cells: recognition and management","volume":"127","author":"Brudno","year":"2016","journal-title":"Blood"},{"key":"B212","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1097\/00001813-199502000-00002","article-title":"Use of corticosteroids in neuro-oncology","volume":"6","author":"Koehler","year":"1995","journal-title":"Anticancer Drugs"},{"key":"B213","doi-asserted-by":"publisher","first-page":"S101","DOI":"10.1016\/j.bbmt.2019.12.603","article-title":"Earlier Steroid Use with Axicabtagene Ciloleucel (Axi-Cel) in Patients with Relapsed\/Refractory Large B Cell Lymphoma (R\/R LBCL)","volume":"26","author":"Topp","year":"2020","journal-title":"Biol Blood Marrow Transplant"},{"key":"B214","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1212\/CON.0000000000000330","article-title":"Acute Multiple Sclerosis Relapse","volume":"22","author":"Berkovich","year":"2016","journal-title":"Contin Minneap Minn"},{"key":"B215","doi-asserted-by":"publisher","DOI":"10.1212\/01.CON.0000433289.38339.a2","article-title":"Acute disseminated encephalomyelitis, transverse myelitis, and neuromyelitis optica","volume":"19","author":"Wingerchuk","year":"2013","journal-title":"Contin Minneap Minn"},{"key":"B216","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2249.2002.01725.x","article-title":"Treatment with methylprednisolone in relapses of multiple sclerosis patients: immunological evidence of immediate and short-term but not long-lasting effects","volume":"127","author":"Mart\u00ednez-C\u00e1ceres","year":"2002","journal-title":"Clin Exp Immunol"},{"key":"B217","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-05-552729","article-title":"Current concepts in the diagnosis and management of cytokine release syndrome","volume":"124","author":"Lee","year":"2014","journal-title":"Blood"},{"key":"B218","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-12-580068","article-title":"CD19-targeted chimeric antigen receptor T-cell therapy for acute lymphoblastic leukemia","volume":"125","author":"Maude","year":"2015","journal-title":"Blood"},{"key":"B219","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a016295","article-title":"IL-6 in Inflammation, Immunity, and Disease","volume":"6","author":"Tanaka","year":"2014","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"B220","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jim.2016.03.005","article-title":"Measuring IL-6 and sIL-6R in serum from patients treated with tocilizumab and\/or siltuximab following CAR T cell therapy","volume":"434","author":"Chen","year":"2016","journal-title":"J Immunol Methods"},{"key":"B221","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-05-155846","article-title":"Mechanisms and pathologic significances in increase in serum interleukin-6 (IL-6) and soluble IL-6 receptor after administration of an anti-IL-6 receptor antibody, tocilizumab, in patients with rheumatoid arthritis and Castleman disease","volume":"112","author":"Nishimoto","year":"2008","journal-title":"Blood"},{"key":"B222","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-05-846428","article-title":"Improved CNS exposure to tocilizumab after cerebrospinal fluid compared to intravenous administration in rhesus macaques","volume":"132","author":"Nellan","year":"2018","journal-title":"Blood"},{"key":"B223","doi-asserted-by":"publisher","DOI":"10.1016\/j.retram.2018.03.004","article-title":"Beginning the CAR T cell therapy revolution in the US and EU","volume":"66","author":"Grupp","year":"2018","journal-title":"Curr Res Transl Med"},{"key":"B224","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-12-3349","article-title":"Open-Label Study of Siltuximab, an Anti\u2013IL-6 Monoclonal Antibody, in Patients with B-cell Non-Hodgkin Lymphoma, Multiple Myeloma, or Castleman Disease","volume":"19","author":"Kurzrock","year":"2013","journal-title":"Clin Cancer Res"},{"key":"B225","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V128.22.2803.2803","article-title":"High Rates of Minimal Residual Disease-Negative (MRD\u2013) Complete Responses (CR) in Adult and Pediatric and Patients With Relapsed\/Refractory Acute Lymphoblastic Leukemia (R\/R ALL) Treated With KTE-C19 (Anti-CD19 Chimeric Antigen Receptor [CAR] T Cells): Preliminary Results of the ZUMA-3 and ZUMA-4 Trials","volume":"128","author":"Shah","year":"2016","journal-title":"Blood"},{"key":"B226","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-018-0041-7","article-title":"CAR T cell-induced cytokine release syndrome is mediated by macrophages and abated by IL-1 blockade","volume":"24","author":"Giavridis","year":"2018","journal-title":"Nat Med"},{"key":"B227","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2018.01157","article-title":"Anakinra Therapy for Non-cancer Inflammatory Diseases","volume":"9","author":"Cavalli","year":"2018","journal-title":"Front Pharmacol"},{"key":"B228","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1186\/s13054-018-2220-9","article-title":"Early therapeutic plasma exchange in septic shock: a prospective open-label nonrandomized pilot study focusing on safety, hemodynamics, vascular barrier function, and biologic markers","volume":"22","author":"Knaup","year":"2018","journal-title":"Crit Care"},{"key":"B229","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcrc.2020.02.010","article-title":"Extracorporeal cytokine removal in severe CAR-T cell associated cytokine release syndrome","volume":"57","author":"Stahl","year":"2020","journal-title":"J Crit Care"},{"key":"B230","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1158\/1078-0432.CCR-18-1379","article-title":"Plasma Exchange Can Be an Alternative Therapeutic Modality for Severe Cytokine Release Syndrome after Chimeric Antigen Receptor-T Cell Infusion: A Case Report","volume":"25","author":"Xiao","year":"2019","journal-title":"Clin Cancer Res Off J Am Assoc Cancer Res"},{"key":"B231","doi-asserted-by":"publisher","DOI":"10.1097\/CJI.0000000000000243","article-title":"Hemofiltration Successfully Eliminates Severe Cytokine Release Syndrome Following CD19 CAR-T-Cell Therapy","volume":"41","author":"Liu","year":"2018","journal-title":"J Immunother"},{"key":"B232","doi-asserted-by":"publisher","first-page":"S39","DOI":"10.1016\/j.bbmt.2019.12.105","article-title":"Risk-Adapted Preemptive Tocilizumab Decreases Severe Cytokine Release Syndrome (CRS) after CTL019 CD19-Targeted Chimeric Antigen Receptor (CAR) T-Cell Therapy for Pediatric B-Cell Acute Lymphoblastic Leukemia (B-ALL)","volume":"26","author":"Myers","year":"2020","journal-title":"Biol Blood Marrow Transplant"},{"key":"B233","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.1996.tb15427.x","article-title":"Drug-induced in vitro inhibition of neutrophil-endothelial cell adhesion","volume":"118","author":"Pellegatta","year":"1996","journal-title":"Br J Pharmacol"},{"key":"B234","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aau5907","article-title":"The tyrosine kinase inhibitor dasatinib acts as a pharmacologic on\/off switch for CAR T cells","volume":"11","author":"Mestermann","year":"2019","journal-title":"Sci Transl Med"},{"key":"B235","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2018028720","article-title":"Pharmacologic control of CAR-T cell function using dasatinib","volume":"3","author":"Weber","year":"2019","journal-title":"Blood Adv"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2020.577027\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,17]],"date-time":"2023-10-17T00:27:24Z","timestamp":1697502444000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2020.577027\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,16]]},"references-count":235,"alternative-id":["10.3389\/fimmu.2020.577027"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2020.577027","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,12,16]]},"article-number":"577027"}}